After vaccination, myocarditis, Guillain-Barré, medical expenses of 10 million won will be provided even if causality is insufficient

[이데일리 박경훈 기자] The quarantine authorities decided to subsidize medical expenses up to 10 million won even if there is insufficient evidence of causality in relation to the development of symptoms such as myocarditis and pericarditis after the COVID-19 vaccine. On the Blue House public petition bulletin board, there are posts urging us to acknowledge side effects such as Guillain-Barré syndrome after vaccination.

On the afternoon of the 6th, people are being vaccinated against COVID-19 at the Vaccination Center in Songpa-gu, Seoul. (Photo=Edaily DB)

Kim Ki-nam, head of the vaccination planning division of the Corona 19 Vaccination Response Promotion Division, said at a regular briefing on the 9th, “From today (9th), the target of the ‘Medical Expense Support Project for Severe Patients’ will be expanded from existing severe patients to special adverse reactions including mild symptoms.” Previously, the quarantine authorities have provided medical expenses of up to 10 million won per person in cases where causality was not recognized due to ‘insufficient evidence’ by the damage investigation team among the cases of hospitalization in the intensive care unit or a disease equivalent to that after vaccination. As of that day, 35 severe patients were classified as eligible for medical expenses, and they suffered from pulmonary embolism, deep vein thrombosis, thrombocytopenic thrombosis, acute disseminated encephalomyelitis, and systemic inflammatory reactions.

Because of this, the vaccinated people who had side effects such as myocarditis, pericarditis, Guillain-Barré syndrome, and erythema multiforme had no place to complain except to the Blue House. In fact, on a bulletin board last month, about two weeks after the vaccination, a message from her daughter asking her to acknowledge the side effects, saying that her father’s face was paralyzed due to Guillain-Barré syndrome.

In the future, all adverse reactions recognized by the World Health Organization (WHO) as requiring active monitoring (observation) after vaccination, such as myocarditis and pericarditis, Guillain-Barré syndrome, and erythema multiforme, will be included in the scope of support.


Share on facebook
Share on twitter
Share on linkedin
Share on pinterest
Share on pocket
Share on whatsapp

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.